Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
1226 results
-
ATAGI Statement on the Omicron variant and the timing of COVID-19 booster vaccination
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) about the COVID-19 Omicron variant and the timing of COVID-19 booster vaccination. -
COVID-19 – Omicron update from CMO Professor Paul Kelly
An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern. -
AHPPC statement on the Omicron public health implications and response options
Australian Health Protection Principal Committee (AHPPC) statement on the public health implications of the Omicron variant and response options. -
Medical Research Future Fund support for clinical trials of mRNA-based vaccines and therapeutics
A new Medical Research Future Fund (MRFF) grant opportunity will support Australian medical research and innovation projects to conduct trials of mRNA-based vaccines and therapeutics. -
$276 million to support Australia’s brightest health scientists
To continue support for Australian health and medical research, the Australian Government is making available $276.4 million through 12 research grant opportunities. Funding is from the Medical Research Future Fund (MRFF). -
COVID-19 vaccination information kiosks open now in Qld, SA, Vic and WA
COVID-19 vaccination information kiosks are now open in shopping centres and events in Queensland, South Australia, Victoria, and Western Australia to help you book a vaccination appointment. -
ATAGI update following weekly COVID-19 meeting – 15 December 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 15 December 2021. -
ATAGI statement on Omicron variant
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) about the COVID-19 Omicron variant. -
Permanent telehealth for all Australians
Temporary telehealth services introduced as part of COVID-19 measures will become a permanent service in our health system. -
2021 National NAIDOC Awards
The National NAIDOC Awards are an opportunity to recognise outstanding achievements by Aboriginal and Torres Strait Islander people at the community, national and international level. -
It’s beginning to look a lot like Christmas…
2021 is quickly coming to an end. With the holidays just around the corner, a lot of us will be travelling interstate and visiting family and friends. -
COVID-19 – Omicron update from CMO Professor Paul Kelly
An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern. -
Refreshed Aboriginal and Torres Strait Islander Health Plan charts new way forward
Today, we released the refreshed National Aboriginal and Torres Strait Islander Health Plan 2021-2031 in partnership between the Australian Government and Aboriginal and Torres Strait Islander health leaders. -
Workshop on rural allied health service and learning consortia
On 1 June 2021, more than 90 stakeholders from all over Australia gathered in Queenstown, Tasmania to discuss service and learning consortia for allied health. -
The National Preventive Health Strategy 2021–2030
The Australian Government has launched the National Preventive Health Strategy 2021–2030, which will provide more balance to the health system by having a stronger focus on preventive health.
-
COVID-19 – Omicron update from CMO Professor Paul Kelly
An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern. -
Australian Technical Advisory Group on Immunisation (ATAGI) recommendations on the use of Spikevax (Moderna) as a COVID-19 booster vaccine
Spikevax (Moderna), also referred to as the Moderna COVID-19 vaccine, has been provisionally approved for use as a COVID-19 booster vaccine in people aged 18 years and older by the Therapeutic Goods Administration (TGA). -
ATAGI statement on the Omicron variant and timing of COVID-19 booster vaccination
The COVID-19 vaccines used in Australia are critical in protecting against COVID-19 due to all variants, including the newly emerged Omicron variant. -
Response to ATAGI advice about vaccinating 5 to 11-year-olds against COVID-19
The latest phase in our COVID-19 vaccination rollout program – to vaccinate children aged 5 to 11 years from 10 January 2022 – continues to be based on the best medical and scientific advice available. -
Australia vaccinating children against COVID-19 from early next year
Australia’s COVID-19 vaccination program will be extended to all children aged 5 to 11 from 10 January 2022 after the Australian Government accepted recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI). -
ATAGI update following weekly COVID-19 meeting – 8 December 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 8 December 2021. -
ATAGI recommendations on Pfizer COVID-19 vaccine use in children aged 5 to 11 years
The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Pfizer COVID-19 vaccine in children aged 5 to 11 years. -
COVID-19 – Omicron update from CMO Professor Paul Kelly
An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern. -
Updated ATAGI advice on the administration of seasonal influenza vaccines in 2021 (December 2021)
As international borders open, the Australian Technical Advisory Group on Immunisation (ATAGI) has issued updated advice for the rollout of influenza vaccines. -
AHPPC statement on national principles for end-to-end best practice managed quarantine arrangements for international travellers
A statement from the Australian Health Protection Principal Committee (AHPPC) on managed quarantine arrangements for international travellers.